Document is current
Any future updates will be listed below
-
Authors
Duplessix, Timothé
Baermann, Ben-Niklas
Hölscher, Alexander Sebastian
Tometten, Inga
Schulz, Felicitas
Munder, Stefanie
Le, Duyen Bao
Jäger, Paul
Nachtkamp, Kathrin
Dietrich, Sascha
Timm, Jörg
Kobbe, Guido
Lübke, Nadine
-
Funding
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
- License Information
-
More Information
Article History
Received: 15 August 2025
Accepted: 4 November 2025
First Online: 20 November 2025
Declarations
:
: N.L. has received honoraria for lectures from Gilead Sciences, Merck Sharp & Dohme (MSD), AbbVie Inc., and ViiV Healthcare. In addition, N.L. has served on advisory boards for ViiV Healthcare, Gilead Sciences, and Theratechnologies Inc., has received consulting fees from ViiV Healthcare and Theratechnologies Inc. (all outside the submitted work) and was supported by Oxford Immunotec/Revvity including provision of the T-SPOT.COMV tests and T-Cell select. F.S. has received honoraria for lectures from AbbVie and travel support from Jazz Pharmaceuticals and AbbVie. KN has received honoraria for lectures from Jazz Pharmaceuticals and travel support from Medac, and has served on advisory boards for BMS: G.K. has received honoraria for advisory boards, presentations and ravel from Abbvie, Amgen, Biotest, BMS-Celgene, Eurocept, Kite-Gilead, Novartis, Medac, MSD, Pfizer, Sanofi and Takeda, as well as financing of scientific research by Abbvie, Amgen, BMS-Celgene, Eurocept and Medac.
